Insulet
PODD
#1019
Rank
NZ$33.04 B
Marketcap
$471.11
Share price
3.90%
Change (1 day)
37.18%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): NZ$0.54 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$1.98 Billion. In 2023 the company made an earning of NZ$0.44 Billion, an increase over its 2022 earnings that were of NZ$76.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.54 B22.48%
2023 NZ$0.44 B481.9%
2022 NZ$76.17 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$97.02 M18.51%
2019 NZ$81.87 M41.16%
2018 NZ$58 M-711.95%
2017 -NZ$9.48 Million-56.85%
2016 -NZ$21.97 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$64.81 Million31.04%
2013 -NZ$49.46 Million-21.96%
2012 -NZ$63.38 Million
2010 -NZ$60.45 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$95.16 Million209.75%
2006 -NZ$30.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$6.81 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.22 Billion-136.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.34 B 126.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.50 B 5,351.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.97 B 1,908.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.46 B 1,654.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$17.93 B 2,908.45%๐Ÿ‡บ๐Ÿ‡ธ USA